China NMPA Product Recall - Modular Hip System

Biomet Spain Orthopaedics S.L., in conjunction with its Chinese responsible unit, Biomet (Shanghai) Trading Co., Ltd., initiated a voluntary recall of certain batches of its Modular Hip System. This recall was reported on February 25, 2013, and published by the National Medical Products Administration (NMPA) on March 20, 2013. The primary issue identified was a manufacturing defect involving a slight protrusion of individual plugs. This defect could prevent the liner from properly fitting into the acetabular cup, potentially compromising the system's intended function as a cementless hip joint prosthesis. The affected product, identified by Registration No. CFDA (Imported) 2011 No. 3481821 and model 1045-48PPS, was distributed in various countries, including China, where 165 units were imported and 160 sold. In response, Biomet implemented several corrective actions under NMPA guidance. These included immediately isolating all unsold and unused products, instructing distributors and users to cease selling and using the affected items, and arranging for all recalled products to be returned to the manufacturer. Additionally, provincial food and drug administrations were directed to strengthen their oversight of this medical device to ensure patient safety.